• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Spectral imaging device offers safe retina test

Article

Glasgow, Scotland-A new, noninvasive method of studying the retina's blood vessels to monitor disease progression could replace the need for fluorescein angiograms.

Glasgow, Scotland-A new, noninvasive method of studying the retina's blood vessels to monitor disease progression could replace the need for fluorescein angiograms.

A team of researchers headed by Sonny Ramachandran from Heriot Watt University in Edinburgh is testing a modified ophthalmoscope that allows them to take pictures of the retina at a series of specific wavelengths.

The spectral imaging device, presented at the Institute of Physics conference Photon '04 in Glasgow, adds a liquid crystal-tuneable filter and captures images with a cooled, low-noise CCD camera. Eye movements can be corrected and digital images stored in a "data cube."

"We are now at the stage of performing much more rigorous trials in a clinical setting, but we hope that this will be a promising new tool," said physicist Andrew Harvey, CPhys, FInstP, one of the project supervisors. "Some of the existing screening techniques, such as fluorescein angiography for diabetic patients, can be painful and in some cases dangerous, with patients dying during treatment. This new technique is safe, quick, and simple, and totally noninvasive, so going for regular check-ups every 4 months won't be so daunting for patients."

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.